Lei P - Search Results

1

Proguanil inhibits proliferation and migration in glioblastoma development through targeting CSF1R receptor.

Ren B, Liang J, Liu Y, Zhang Y, Ma X, Lei P, Gao J, Ma W. Ren B, et al. Among authors: lei p. Cell Signal. 2024 Dec 9;127:111550. doi: 10.1016/j.cellsig.2024.111550. Online ahead of print. Cell Signal. 2024. PMID: 39662608

2

Pseudolaric Acid B Inhibits FLT4-induced Proliferation and Migration in Non-small Cell Lung Cancer.

Lei P, Liang J, Su X, Gao J, Ren B, Ma X, Zhang Y, Ma W. Lei P, et al. Anticancer Agents Med Chem. 2024;24(19):1419-1430. doi: 10.2174/0118715206313028240819103933. Anticancer Agents Med Chem. 2024. PMID: 39192640

3

ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling.

Liu YH, Zhu M, Lei PP, Pan XY, Ma WN. Liu YH, et al. Oncol Rep. 2021 Jul;46(1):136. doi: 10.3892/or.2021.8087. Epub 2021 May 26. Oncol Rep. 2021. PMID: 34036393 Free PMC article.

4

β₂-adrenergic receptor affinity chromatography with an interaction force analysis model: A method for analysis of active compounds targeting β₂-adrenergic receptor.

Ma W, Yang L, Liu Y, Lei P, Zhang Y. Ma W, et al. Among authors: lei p. J Chromatogr A. 2021 Aug 30;1652:462371. doi: 10.1016/j.chroma.2021.462371. Epub 2021 Jun 29. J Chromatogr A. 2021. PMID: 34242937

5

Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.

Ma W, Liu Y, Lei P, Zhu M, Pan X. Ma W, et al. Among authors: lei p. Curr Cancer Drug Targets. 2022;22(5):404-413. doi: 10.2174/1568009622666220304202116. Curr Cancer Drug Targets. 2022. PMID: 35249489

6

Thebaine induces anaphylactic reactions via the MRGPRX2 receptor pathway on mast cells.

Lei P, Liu Y, Ding Y, Su X, Liang J, Chen H, Ma W. Lei P, et al. Cell Immunol. 2022 May;375:104514. doi: 10.1016/j.cellimm.2022.104514. Epub 2022 Apr 2. Cell Immunol. 2022. PMID: 35398603

7

Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner.

Liang J, Lei P, Su X, Gao J, Ren B, Zhang Y, Ma X, Ma W. Liang J, et al. Among authors: lei p. Curr Cancer Drug Targets. 2024;24(11):1157-1168. doi: 10.2174/0115680096282997240101192452. Curr Cancer Drug Targets. 2024. PMID: 38321898

8

In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.

Gao J, Lei P, Su X, Liang J, Ren B, Ma X, Zhang Y, Zhang Y, Ma W. Gao J, et al. Among authors: lei p. Phytomedicine. 2024 Jul;129:155582. doi: 10.1016/j.phymed.2024.155582. Epub 2024 Apr 4. Phytomedicine. 2024. PMID: 38608595

9

Harringtonine metabolites: 5'-de-O-methylharringtonine and cephalotaxine, targeting spike protein and TMPRSS2 to double block membrane fusion of SARS-CoV-2 and its variants.

Gao J, Hu S, Ma X, Zhang Y, Ren B, Lei P, Ma W, He L. Gao J, et al. Among authors: lei p. Eur J Pharmacol. 2024 Nov 15;983:177012. doi: 10.1016/j.ejphar.2024.177012. Epub 2024 Sep 18. Eur J Pharmacol. 2024. PMID: 39304111

10

Cell membrane chromatography relative competitive method for the accurate determination of relative K_D values of drug-receptor interactions.

Lei P, Ma W, Gao J, Ren B, Ma X, Zhang Y, Su X, Liang J, He L. Lei P, et al. Arch Pharm Res. 2024 Dec 10. doi: 10.1007/s12272-024-01525-x. Online ahead of print. Arch Pharm Res. 2024. PMID: 39658753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,455 results

Search Page

Filters